NEW YORK (GenomeWeb News) — The Beijing Genomics Institute’s BGI LifeTech segment will sell DNAStar’s bioinformatics software in China and Hong Kong, DNAStar said today.

Under the agreement, BGI LifeTech has acquired the rights to sell the Lasergene, ArrayStar, Seqman Genome Assembler, and GenVision products.
 
The company’s software platforms are used in analyzing sequence data, microarray gene expression data, and genomic visualizations.

Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.